A great deal on the legislative activity has stemmed from Purdue Pharma's decision in 2011 to start a modification of Oxycontin's composition to make it more challenging to crush for snorting or injecting. The new formulation, OxyNeo, is meant to get preventive In this particular regard and keep its effectiveness as a painkiller. Since introducing